Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -81.68M
March 31, 2026 -82.90M
December 31, 2025 -79.85M
September 30, 2025 -68.22M
June 30, 2025 -32.89M
March 31, 2025 -33.01M
December 31, 2024 -38.53M
September 30, 2024 -42.02M
June 30, 2024 -40.22M
March 31, 2024 -33.44M
December 31, 2023 -22.74M
September 30, 2023 -20.45M
June 30, 2023 -33.87M
March 31, 2023 -47.10M
December 31, 2022 -60.22M
September 30, 2022 -67.06M
June 30, 2022 -66.44M
March 31, 2022 -70.44M
December 31, 2021 -61.52M
September 30, 2021 -45.90M
Date Value
June 30, 2021 -36.51M
March 31, 2021 -27.86M
December 31, 2020 -27.30M
September 30, 2020 -35.25M
June 30, 2020 -36.34M
March 31, 2020 -39.37M
December 31, 2019 -37.03M
September 30, 2019 -40.18M
June 30, 2019 -38.23M
March 31, 2019 -31.00M
December 31, 2018 -30.24M
September 30, 2018 -26.75M
June 30, 2018 -27.02M
March 31, 2018 -29.59M
December 31, 2017 -23.24M
September 30, 2017 -22.82M
June 30, 2017 -21.16M
March 31, 2017 -19.38M
December 31, 2016 -18.27M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Lifecore Biomedical, Inc. --
Codexis, Inc. -12.18M
Frontage Holdings Corp. 32.58M
Repligen Corp. 110.15M
Bio-Techne Corp. 263.22M